{"id":"https://openalex.org/W3133533660","doi":"https://doi.org/10.12788/jcso.0124","title":"Effectiveness and safety of ipilimumab therapy in advanced melanoma: evidence from clinical practice sites in the US","display_name":"Effectiveness and safety of ipilimumab therapy in advanced melanoma: evidence from clinical practice sites in the US","publication_year":2015,"publication_date":"2015-04-01","ids":{"openalex":"https://openalex.org/W3133533660","doi":"https://doi.org/10.12788/jcso.0124","mag":"3133533660"},"language":"en","primary_location":{"id":"doi:10.12788/jcso.0124","doi":"https://doi.org/10.12788/jcso.0124","is_oa":true,"landing_page_url":"https://doi.org/10.12788/jcso.0124","pdf_url":"https://cdn.mdedge.com/files/s3fs-public/issues/articles/JCSO_April_2015_133_Rao.pdf","source":{"id":"https://openalex.org/S2764867131","display_name":"The Journal of Community and Supportive Oncology","issn_l":"2330-7749","issn":["2330-7749","2330-7757"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","poland-40","russia-white-list-4"],"host_organization":"https://openalex.org/P4322696809","host_organization_name":"Frontline Medical Communications","host_organization_lineage":["https://openalex.org/P4322696809"],"host_organization_lineage_names":["Frontline Medical Communications"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Community and Supportive Oncology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://cdn.mdedge.com/files/s3fs-public/issues/articles/JCSO_April_2015_133_Rao.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5084347950","display_name":"Kim Allyson Margolin","orcid":"https://orcid.org/0000-0002-5248-4356","observed_orcids":["https://orcid.org/0000-0002-5248-4356","https://orcid.org/0000-0002-5718-7422"]},"institutions":[{"id":"https://openalex.org/I201448701","display_name":"University of Washington","ror":"https://ror.org/00cvxb145","country_code":"US","type":"education","lineage":["https://openalex.org/I201448701"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kim Margolin","raw_affiliation_strings":["University of Washington, Seattle, Washington;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Washington, Seattle, Washington;","institution_ids":["https://openalex.org/I201448701"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020955148","display_name":"Ahmad A. Tarhini","orcid":"https://orcid.org/0000-0002-3193-9702","observed_orcids":["https://orcid.org/0000-0002-3193-9702"]},"institutions":[{"id":"https://openalex.org/I170201317","display_name":"University of Pittsburgh","ror":"https://ror.org/01an3r305","country_code":"US","type":"education","lineage":["https://openalex.org/I170201317"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ahmad Tarhini","raw_affiliation_strings":["University of Pittsburgh, Pittsburgh, Pennsylvania;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Pittsburgh, Pittsburgh, Pennsylvania;","institution_ids":["https://openalex.org/I170201317"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109110234","display_name":"Sumati A. Rao","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Sumati Rao","raw_affiliation_strings":["Bristol-Myers Squibb, Plainsboro, New Jersey;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bristol-Myers Squibb, Plainsboro, New Jersey;","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111073149","display_name":"Monica Katyal","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Monica Katyal","raw_affiliation_strings":["Medical Data Analytics, Parsippany, New Jersey;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Data Analytics, Parsippany, New Jersey;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113724672","display_name":"I\u2010Fen Chang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"I-Fen Chang","raw_affiliation_strings":["Bristol-Myers Squibb, Plainsboro, New Jersey;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bristol-Myers Squibb, Plainsboro, New Jersey;","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025067315","display_name":"Douglas Buckner Johnson","orcid":"https://orcid.org/0000-0002-6390-773X","observed_orcids":["https://orcid.org/0000-0002-6390-773X"]},"institutions":[{"id":"https://openalex.org/I901861585","display_name":"Vanderbilt University Medical Center","ror":"https://ror.org/05dq2gs74","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210162197","https://openalex.org/I901861585"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Douglas Johnson","raw_affiliation_strings":["Vanderbilt University Medical Center , Nashville , Ten ne s s e e ;","Vanderbilt University Medical Center, Nashville, Ten ne"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vanderbilt University Medical Center , Nashville , Ten ne s s e e ;","institution_ids":["https://openalex.org/I901861585"]},{"raw_affiliation_string":"Vanderbilt University Medical Center, Nashville, Ten ne","institution_ids":["https://openalex.org/I901861585"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109602066","display_name":"Sekwon Jang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285739803","display_name":"MedStar Washington Hospital Center","ror":"https://ror.org/05ry42w04","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1285739803","https://openalex.org/I86755215"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sekwon Jang","raw_affiliation_strings":["Washington Cancer Institute at MedStar Washington Hospital Center, Washington, DC;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Washington Cancer Institute at MedStar Washington Hospital Center, Washington, DC;","institution_ids":["https://openalex.org/I1285739803"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034792001","display_name":"Joseph I. Clark","orcid":"https://orcid.org/0000-0002-0455-2625","observed_orcids":["https://orcid.org/0000-0002-0455-2625"]},"institutions":[{"id":"https://openalex.org/I1304196042","display_name":"Loyola University Medical Center","ror":"https://ror.org/05xcyt367","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1304196042","https://openalex.org/I1304269903"]},{"id":"https://openalex.org/I4210159390","display_name":"Loyola Medicine","ror":"https://ror.org/04azs9g49","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210159390"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Joseph Clark","raw_affiliation_strings":["Loyola University Medical Center, Cardinal Bernardin Cancer Center, Maywood, Illinois; and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Loyola University Medical Center, Cardinal Bernardin Cancer Center, Maywood, Illinois; and","institution_ids":["https://openalex.org/I1304196042","https://openalex.org/I4210159390"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5007052233","display_name":"David F. McDermott","orcid":"https://orcid.org/0000-0002-2675-5095","observed_orcids":["https://orcid.org/0000-0002-2675-5095","https://orcid.org/0000-0001-6978-0867"]},"institutions":[{"id":"https://openalex.org/I1316535847","display_name":"Beth Israel Deaconess Medical Center","ror":"https://ror.org/04drvxt59","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316535847"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David McDermott","raw_affiliation_strings":["Beth Israel Deaconess Medical Center, Boston, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Beth Israel Deaconess Medical Center, Boston, Massachusetts","institution_ids":["https://openalex.org/I1316535847"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":8,"corresponding_author_ids":["https://openalex.org/A5109110234"],"corresponding_institution_ids":["https://openalex.org/I4210091812"],"apc_list":null,"apc_paid":null,"fwci":0.8735,"has_fulltext":true,"cited_by_count":6,"citation_normalized_percentile":{"value":0.77582746,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":98},"biblio":{"volume":"13","issue":"4","first_page":"131","last_page":"138"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9487000107765198,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9487000107765198,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10392","display_name":"Cutaneous Melanoma Detection and Management","score":0.04729999974370003,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11533","display_name":"Melanoma and MAPK Pathways","score":0.0007999999797903001,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ipilimumab","display_name":"ipilimumab","score":1.0},{"id":"https://openalex.org/keywords/advanced-melanoma","display_name":"advanced melanoma","score":0.9950000047683716},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.6610000133514404},{"id":"https://openalex.org/keywords/treatment-effectiveness","display_name":"treatment effectiveness","score":0.7409999966621399},{"id":"https://openalex.org/keywords/treatment-safety","display_name":"treatment safety","score":0.8650000095367432},{"id":"https://openalex.org/keywords/real-world-evidence","display_name":"real-world evidence","score":0.6800000071525574},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.6480000019073486},{"id":"https://openalex.org/keywords/metastatic-melanoma","display_name":"metastatic melanoma","score":0.921999990940094}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9449992179870605},{"id":"https://openalex.org/C2781433595","wikidata":"https://www.wikidata.org/wiki/Q2459042","display_name":"Ipilimumab","level":4,"score":0.9345566034317017},{"id":"https://openalex.org/C2777658100","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Melanoma","level":2,"score":0.672853946685791},{"id":"https://openalex.org/C2779974597","wikidata":"https://www.wikidata.org/wiki/Q28448986","display_name":"Clinical Practice","level":2,"score":0.4565514922142029},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.42897728085517883},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.3898767828941345},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3847823441028595},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.3644125759601593},{"id":"https://openalex.org/C19527891","wikidata":"https://www.wikidata.org/wiki/Q1120908","display_name":"Medical physics","level":1,"score":0.34509044885635376},{"id":"https://openalex.org/C512399662","wikidata":"https://www.wikidata.org/wiki/Q3505712","display_name":"Family medicine","level":1,"score":0.2785424590110779},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.1297876238822937},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.10813575983047485},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.05599480867385864}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.12788/jcso.0124","doi":"https://doi.org/10.12788/jcso.0124","is_oa":true,"landing_page_url":"https://doi.org/10.12788/jcso.0124","pdf_url":"https://cdn.mdedge.com/files/s3fs-public/issues/articles/JCSO_April_2015_133_Rao.pdf","source":{"id":"https://openalex.org/S2764867131","display_name":"The Journal of Community and Supportive Oncology","issn_l":"2330-7749","issn":["2330-7749","2330-7757"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","poland-40","russia-white-list-4"],"host_organization":"https://openalex.org/P4322696809","host_organization_name":"Frontline Medical Communications","host_organization_lineage":["https://openalex.org/P4322696809"],"host_organization_lineage_names":["Frontline Medical Communications"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Community and Supportive Oncology","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.12788/jcso.0124","doi":"https://doi.org/10.12788/jcso.0124","is_oa":true,"landing_page_url":"https://doi.org/10.12788/jcso.0124","pdf_url":"https://cdn.mdedge.com/files/s3fs-public/issues/articles/JCSO_April_2015_133_Rao.pdf","source":{"id":"https://openalex.org/S2764867131","display_name":"The Journal of Community and Supportive Oncology","issn_l":"2330-7749","issn":["2330-7749","2330-7757"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","poland-40","russia-white-list-4"],"host_organization":"https://openalex.org/P4322696809","host_organization_name":"Frontline Medical Communications","host_organization_lineage":["https://openalex.org/P4322696809"],"host_organization_lineage_names":["Frontline Medical Communications"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Community and Supportive Oncology","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G4872119764","display_name":null,"funder_award_id":"K12 CA 0906525","funder_id":"https://openalex.org/F4320332161","funder_display_name":"National Institutes of Health"}],"funders":[{"id":"https://openalex.org/F4320307115","display_name":"Bristol-Myers Squibb","ror":"https://ror.org/00gtmwv55"},{"id":"https://openalex.org/F4320308296","display_name":"Melanoma Research Alliance","ror":"https://ror.org/025ck6r46"},{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W3133533660.pdf","grobid_xml":"https://content.openalex.org/works/W3133533660.grobid-xml"},"referenced_works_count":13,"referenced_works":["https://openalex.org/W1557490668","https://openalex.org/W1966999467","https://openalex.org/W2097995306","https://openalex.org/W2103220202","https://openalex.org/W2109653150","https://openalex.org/W2116362236","https://openalex.org/W2123363005","https://openalex.org/W2133075384","https://openalex.org/W2137723371","https://openalex.org/W2138134458","https://openalex.org/W2151592384","https://openalex.org/W2155104279","https://openalex.org/W2157709266"],"related_works":["https://openalex.org/W2260727069","https://openalex.org/W1994979268","https://openalex.org/W2344981827","https://openalex.org/W2938028594","https://openalex.org/W159077070","https://openalex.org/W2913579963","https://openalex.org/W2254875398","https://openalex.org/W2413726843","https://openalex.org/W4213289306","https://openalex.org/W2938139176"],"abstract_inverted_index":{"he":[0],"incidence":[1],"of":[2,8,25,80,88,141],"melanoma,":[3],"the":[4,26,44,109],"most":[5,15],"serious":[6],"form":[7],"skin":[9],"cancer,":[10],"is":[11],"rising":[12],"globally.1,2":[13],"Although":[14],"patients":[16,35,90],"are":[17],"diagnosed":[18],"and":[19,28,107],"treated":[20],"at":[21,127],"an":[22,47,63],"early":[23],"stage":[24,138],"disease":[27],"have":[29],"a":[30,74,83,86],"good":[31],"prognosis,":[32,76],"survival":[33,79,112],"among":[34],"with":[36,69,77,91,102,122],"unresectable":[37],"or":[38],"metastatic":[39],"(advanced)":[40],"melanoma":[41,52,60,71,93,140],"remains":[42],"poor.In":[43],"United":[45],"States,":[46],"estimated":[48,64,134],"9,940":[49],"deaths":[50,66],"from":[51,94],"will":[53],"occur":[54],"in":[55,58],"2015;":[56],"1":[57,128],"Europe,":[59],"accounts":[61],"for":[62,137],"20,000":[65],"annually.2":[67],"Patients":[68],"advanced":[70,92],"historically":[72],"had":[73],"dismal":[75],"median":[78,110,135],"less":[81],"than":[82],"year.3,4":[84],"In":[85],"meta-analysis":[87],"2,100":[89],"42":[95],"phase":[96],"2":[97],"cooperative":[98],"group":[99],"clinical":[100],"trials":[101],"accrual":[103],"closing":[104],"between":[105],"1975":[106],"2005,":[108],"overall":[111],"(OS)":[113],"was":[114],"6.2":[115],"months":[116],"(95%":[117,124],"confdence":[118],"interval":[119],"[CI],":[120],"5.9-6.5),":[121],"25.5%":[123],"CI,":[125],"23.6-27.4)alive":[126],"year.3":[129],"Another":[130],"recent":[131],"systematic":[132],"review":[133],"OS":[136],"IV":[139],"about":[142],"8":[143],"months,":[144]},"counts_by_year":[{"year":2018,"cited_by_count":1},{"year":2015,"cited_by_count":5}],"updated_date":"2026-10-30T12:39:25.321706","created_date":"2021-03-15T00:00:00"}